{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:04:20Z","timestamp":1761307460331,"version":"build-2065373602"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Lymphatic malformations (LMs) of the extremities present a therapeutic challenge due to their diffuse infiltration of subcutaneous and deep fascial compartments, often complicated by previous treatment failures and high recurrence rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a pilot study to evaluate the feasibility and safety of a novel minimally invasive technique, endoscopic-assisted plasma radiofrequency ablation (EPRA), in managing complex extremity LMs. Between November 2024 and April 2025, 5 patients with recurrent, multilayered LMs involving the thigh, knee, or calf underwent EPRA under general anesthesia. Magnetic resonance imaging and multidisciplinary evaluation confirmed preoperative diagnosis and lesion mapping. The procedure used small incisions for endoscopic access, continuous saline irrigation for hydrodissection, and bipolar radiofrequency ablation to selectively coagulate aberrant lymphatic vessels under direct visualization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>All cases were completed without conversion to open surgery, with a mean operative time of 60 minutes. No major complications were observed, and transient postoperative edema resolved spontaneously within 1 week. At short-term follow-up, patients demonstrated functional preservation and satisfactory cosmetic outcomes, with no evidence of early recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The EPRA technique offers a promising therapeutic alternative that combines the precision of endoscopy with the targeted energy delivery of radiofrequency ablation, thereby minimizing collateral damage and reducing the risks associated with conventional sclerotherapy or open resection. This initial experience supports the feasibility and safety of EPRA for extremity LMs, particularly in anatomically complex or treatment-refractory cases, and provides a foundation for future studies with expanded patient cohorts and long-term outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/gox.0000000000007222","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:00:35Z","timestamp":1761307235000},"page":"e7222","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pilot Study: Endoscopic-assisted Plasma Radiofrequency Ablation: A Minimally Invasive Strategy for Extremity Lymphatic Malformations"],"prefix":"10.1097","volume":"13","author":[{"given":"Ren","family":"Cai","sequence":"first","affiliation":[{"name":"Department of Interventional Therapy, Multidisciplinary Team of Vascular Anomalies, Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifeng","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Interventional Therapy, Multidisciplinary Team of Vascular Anomalies, Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxue","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Interventional Therapy, Multidisciplinary Team of Vascular Anomalies, Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,10]]},"reference":[{"key":"R1-20251024","doi-asserted-by":"crossref","first-page":"e172844","DOI":"10.1172\/JCI172844","article-title":"Lymphatic malformations: mechanistic insights and evolving therapeutic frontiers.","volume":"134","author":"Petkova","year":"2024","journal-title":"J Clin Invest"},{"key":"R2-20251024","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s11886-024-02120-8","article-title":"Lymphatic system development and function.","volume":"26","author":"Janardhan","year":"2024","journal-title":"Curr Cardiol Rep"},{"key":"R3-20251024","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCRESAHA.121.318142","article-title":"Lymphatic malformations: genetics, mechanisms and therapeutic strategies.","volume":"129","author":"M\u00e4kinen","year":"2021","journal-title":"Circ Res"},{"key":"R4-20251024","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/lrb.2020.0047","article-title":"Expression of cathepsins B, D, and G in microcystic lymphatic malformation.","volume":"19","author":"Mehrotra","year":"2021","journal-title":"Lymphat Res Biol"},{"key":"R5-20251024","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jpeds.2019.12.004","article-title":"Micro- and macrocystic lymphatic malformation.","volume":"219","author":"McCormack","year":"2020","journal-title":"J Pediatr"},{"key":"R6-20251024","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1089\/lrb.2023.29147.editorial","article-title":"Lymphatic malformations: what can we learn from the fluid.","volume":"21","author":"Rockson","year":"2023","journal-title":"Lymphat Res Biol"},{"key":"R7-20251024","doi-asserted-by":"crossref","first-page":"100631","DOI":"10.1016\/j.tvir.2019.100631","article-title":"Common (cystic) lymphatic malformations: current knowledge and management.","volume":"22","author":"Dubois","year":"2019","journal-title":"Tech Vasc Interv Radiol"},{"key":"R8-20251024","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/pde.14526","article-title":"Net-like superficial lymphatic malformation.","volume":"38","author":"Iznardo","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"R9-20251024","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s00405-023-07844-x","article-title":"Association between malformation type, location and functional deficits in lymphatic malformations of the head and neck in children.","volume":"280","author":"Wiegand","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R10-20251024","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cps.2010.08.006","article-title":"Management of lymphatic malformations.","volume":"38","author":"Greene","year":"2011","journal-title":"Clin Plast Surg"},{"key":"R11-20251024","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/SAP.0000000000003065","article-title":"Management of macrocystic lymphatic malformation in the cervicofacial region: ultrasound-guided iodine tincture cauterization combined with intralesional negative pressure.","volume":"88","author":"Han","year":"2022","journal-title":"Ann Plast Surg"},{"key":"R12-20251024","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/pde.15202","article-title":"Curettage and sclerotherapy technique: a hybrid approach to superficial lymphatic malformation.","volume":"40","author":"Wang","year":"2023","journal-title":"Pediatr Dermatol"},{"key":"R13-20251024","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/lrb.2019.29071.sr","article-title":"Progress in the approach to lymphatic vascular malformation.","volume":"17","author":"Rockson","year":"2019","journal-title":"Lymphat Res Biol"},{"key":"R14-20251024","doi-asserted-by":"crossref","first-page":"e242728","DOI":"10.1148\/radiol.242728","article-title":"Case 338: right retroperitoneal lymphatic-venous malformation.","volume":"315","author":"Shah","year":"2025","journal-title":"Radiology"},{"key":"R15-20251024","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.jpedsurg.2020.09.007","article-title":"Histopathological evaluation of the effectiveness of oral Eppikajutsuto treatment for lymphatic malformation.","volume":"56","author":"Matsudera","year":"2021","journal-title":"J Pediatr Surg"},{"key":"R16-20251024","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1089\/lrb.2017.0062","article-title":"Treatment of lymphatic malformations with the mTOR inhibitor sirolimus: a systematic review.","volume":"16","author":"Wiegand","year":"2018","journal-title":"Lymphat Res Biol"},{"key":"R17-20251024","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12887-020-02337-w","article-title":"Ultrasonographic diagnosis, classification, and treatment of cervical lymphatic malformation in paediatric patients: a retrospective study.","volume":"20","author":"Li","year":"2020","journal-title":"BMC Pediatr"},{"key":"R18-20251024","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jaad.2023.07.1043","article-title":"Verrucous venous malformation and lymphatic malformation, former similar phenotypes where cell-free DNA could clarify in genotype.","volume":"90","author":"Sun","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"R19-20251024","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jamadermatol.2022.2793","article-title":"Treatment with topical sirolimus for recurrent lymphatic malformation of the external urethral meatus.","volume":"158","author":"Yonekura","year":"2022","journal-title":"JAMA Dermatol"},{"key":"R20-20251024","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/j.jaad.2019.01.056","article-title":"Topical rapamycin in superficial lymphatic malformation: microcystic lymphatic malformation or verrucous venous malformation?","volume":"88","author":"Cai","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"R21-20251024","doi-asserted-by":"crossref","first-page":"151422","DOI":"10.1016\/j.sempedsurg.2024.151422","article-title":"Complex lymphatic anomalies: molecular landscape and medical management.","volume":"33","author":"Borst","year":"2024","journal-title":"Semin Pediatr Surg"}],"container-title":["Plastic and Reconstructive Surgery - Global Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GOX.0000000000007222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:00:39Z","timestamp":1761307239000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GOX.0000000000007222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":21,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/gox.0000000000007222","relation":{},"ISSN":["2169-7574"],"issn-type":[{"type":"electronic","value":"2169-7574"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}